Page 25 - Mylan EpiPen Teaching Note
P. 25

SALES & REVENUE


                 For Mylan EpiPen is a complex prescription product,

                 implying it’s not something a do-it-yourselfer can make in

                 a garage. But, alternatives do exist and it has been shown
                 by its latest recall that even large industrial

                 manufacturers can get it wrong. Competition is growing

                 and rapidly eroding Mylan’s profits.


















































                 The introduction of a generic alternative of the EpiPen by

                 Mylan is unusual because the branded version is still

                 under patent and other rival treatments failed to get
                 regulatory clearance until very recently.
   20   21   22   23   24   25   26   27   28   29   30